D.E. Shaw & Co’s Genprex GNPX Stock Holding History

D.E. Shaw & Co’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3	Closed	-$164K	–	5680
2021 Q4	$164K	Buy	3 +1	+50%	+$83.4K	﹤0.01%	4941
2021 Q3	$230K	Buy	2 +1	+100%	+$129K	﹤0.01%	4501
2021 Q2	$95K	Buy	+1	New	+$164K	﹤0.01%	4558

Other funds holding GNPX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $370M AUM 16.36% 1-Year Est. Return

D.E. Shaw & Co's GNPX Position: Q1 2022 in Review

D.E. Shaw & Co sold out of Genprex (GNPX) in Q1 2022, closing a stake of 3 shares — an estimated $164K sold.

D.E. Shaw & Co first reported a position in GNPX in Q2 2021 and held it in 3 quarters. The position peaked at $230K in Q3 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q1 2022.

D.E. Shaw & Co reported no remaining Genprex position as of Q1 2022 after selling out during the quarter.
D.E. Shaw & Co sold 3 Genprex shares in Q1 2022, an estimated $164K.
D.E. Shaw & Co first reported a position in Genprex in Q2 2021 and held it in 3 quarters.
D.E. Shaw & Co's Genprex position peaked at $230K in Q3 2021.
20 funds tracked by Wall St. Rank held Genprex as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.